TNT009: Interim Phase Ib data

Interim data from 5 patients with cold agglutinin disease (CAD) in Part C of a 3-part, double-blind, Austrian Phase Ib trial showed that a single dose of 10 mg/kg IV

Read the full 307 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE